Search
WAVE Life Sciences Ltd
WVEAdd to Watchlist
6.260USD
+0.420+7.19%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM
More Details of WAVE Life Sciences Ltd Company
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).
WAVE Life Sciences Ltd Info
Ticker SymbolWVE
Company nameWAVE Life Sciences Ltd
IPO dateNov 11, 2015
CEOBolno (Paul B)
Number of employees287
Security typeOrdinary Share
Fiscal year-endNov 11
Address7 Straits View
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountrySingapore
Postal code018936
Phone6562363388
Websitehttps://www.wavelifesciences.com/
Ticker SymbolWVE
IPO dateNov 11, 2015
CEOBolno (Paul B)
Company Executives of WAVE Life Sciences Ltd
Name
Name/Position
Position
Shareholding
Change
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%
Dr. Mark H. N. Corrigan, M.D.
Dr. Mark H. N. Corrigan, M.D.
Independent Director
Independent Director
--
--
Ms. Aik Na Tan
Ms. Aik Na Tan
Independent Director
Independent Director
--
-100.00%
Dr. Paul B. Bolno, M.D.
Dr. Paul B. Bolno, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Gregory L. (Greg) Verdine, Ph.D.
Dr. Gregory L. (Greg) Verdine, Ph.D.
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%
FAQs
Who are the top five shareholders of WAVE Life Sciences Ltd?
The top five shareholders of WAVE Life Sciences Ltd are: Dr. Chandra Vargeese, Ph.D.